Celem badania była ocena wczesnej skuteczności leczenia anty-TNFu chorych na zesztywniające zapalenie stawów kręgosłupa (ZZSK).Badaniem objęto 34 osoby (10 kobiet i 24 mężczyzn w wieku średnio39 lat), chorych na aktywną postać ZZSK, zakwalifikowanych ...
Artur Bachta +3 more
doaj
PReS-FINAL-2185: Prognostic markers in juvenile vs. adult-onset ankylosing spondylitis [PDF]
AV Ramanan +4 more
core +1 more source
Impact of disease burden on VO<sub>2</sub>max, physical performance and frailty in ankylosing spondylitis: a comparative cross-sectional study. [PDF]
Tariq A, Ammar M, Saad A, Zadeh SAM.
europepmc +1 more source
e30 An audit to assess the rate of physiotherapy referral and BASMI measurements for patients with ankylosing spondylitis in the general rheumatology clinic at Sheffield Teaching Hospitals [PDF]
Mithun Chakravorty +2 more
openaire +1 more source
Evaluation of palatal bone thickness and palatal depth angle for optimal mini-implant placement in MARPE: A CBCT study. [PDF]
Al-Basmi AA +4 more
europepmc +1 more source
In this study we evaluated magnetic resonance imaging (MRI) changes in ankylosing spondylitis (AS) patients and investigated whether there is any relationship between MRI findings and validated methods of disease assessment. A total of 40 patients were included in this cross-sectional study (29 men, 11 women).
openaire +1 more source
The effectiveness of different exercise mode interventions in improving disease activity in patients with ankylosing spondylitis: a network and dose-dependent meta-analysis. [PDF]
Ye G +7 more
europepmc +1 more source
Transcriptomic and proteomic analysis stratifies patients with axial spondyloarthritis based on disease activity, structural damage and radiographic progression. [PDF]
Cuesta-López L +16 more
europepmc +1 more source
Real-World Effectiveness and Safety of Upadacitinib in Tumor Necrosis FactorInhibitor Refractory Axial Spondyloarthritis: 52-Week Outcomes from a Single-Center Cohort. [PDF]
Bakay U, İzci Duran T.
europepmc +1 more source
Efficacy of Tofacitinib in Refractory Axial Spondylarthritis: A Dose-Escalation Study. [PDF]
Tazbir AM +7 more
europepmc +1 more source

